Litcius/Paper detail

HERMES: Effects Of Ziltivekimab Versus Placebo On Morbidity And Mortality In Patients With Heart Failure With Mildly Reduced Or Preserved Ejection Fraction And Systemic Inflammation

Mark C. Petrie, Barry A. Borlaug, Kristine Buchholtz, Anique Ducharme, Anders Hvelplund, Carolyn Lam Su Ping, Guiomar Mendieta, Søren Hardt‐Lindberg, Adriaan A. Voors, Paul M. Ridker

2024Journal of Cardiac Failure51 citationsDOI

Topics & Concepts

MedicineHeart failureEjection fractionInternal medicineCardiologyNatriuretic peptideSystemic inflammationPlaceboHeart failure with preserved ejection fractionAdverse effectClinical trialInflammationPathologyAlternative medicineCardiac Fibrosis and RemodelingGDF15 and Related BiomarkersHeart Failure Treatment and Management
HERMES: Effects Of Ziltivekimab Versus Placebo On Morbidity And Mortality In Patients With Heart Failure With Mildly Reduced Or Preserved Ejection Fraction And Systemic Inflammation | Litcius